Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -11.004\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] Cc1ccc(CCCOC(=O)CN2CCCCC2)cc1
[b] COc1ccc(C)cc1NC(=O)NNC(=O)C1CCC(C(C)(C)C)CC1
[c] CCOC(=O)CNC(c1ccccc1)c1cc(Br)ccc1NC(=O)CCN1CCOCC1
Answer: c. CCOC(=O)CNC(c1ccccc1)c1cc(Br)ccc1NC(=O)CCN1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)CNC(c1ccccc1)c1cc(Br)ccc1NC(=O)CCN1CCOCC1
CCOC(=O)CNC(c1ccccc1)c1cc(Br)ccc1NC(=O)CCN1CCOCC1
N-[4-bromo-2-[[(2-ethoxy-2-oxoethyl)amino]-phenylmethyl]phenyl]-3-morpholin-4-ylpropanamide